NCT05785767 2026-01-22A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)Regeneron PharmaceuticalsPhase 2/3 Active not recruiting850 enrolled